Patients at the greatest risk for secondary infections, particularly infections that are resistant to first-line antibiotics, include people who are already vulnerable due to other conditions and diseases—like COVID-19. Because of that, antimicrobial resistance poses a significant additional threat, especially as healthcare systems become overburdened.
COVID-19 and the Value of Vaccines
With the COVID-19 pandemic having reached over 170 countries, and cases skyrocketing in the United States and other nations, scientists around the world are working as fast as they can to develop a vaccine for SARS-CoV-2, the virus that causes COVID-19.
Your Questions About Coronavirus and Food Safety, Answered
Minimizing contact with others through social distancing is crucial to flatten the curve and reduce the rate of coronavirus infection. However, many people are wondering if it’s still possible to transmit the virus via food and pickup or delivery services.
Responding to COVID-19 in a Climate of Uncertainty
As COVID-19 continues to spread, misinformation has often been more contagious than the virus itself, and a lack of concrete information in some areas has compounded the problem.
The Value of Diagnostics in Combatting Antimicrobial Resistance – A Public Health Problem
At this year’s World Anti-Microbial Resistance Congress, Dr. Tristan Timbrook delivered a...
Lindsay Denny Discusses the Critical Role of WASH in Preventing Infectious Diseases and Fighting Antimicrobial Resistance
WASH, which stands for water, sanitation, and hygiene, are basic...